Method of treating pancreatic cancer
US-2024415804-A1 · Dec 19, 2024 · US
Method for preventing and/or treating a subject suffering from asthma
US9868716B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9868716-B2 |
| Application number | US-201514824763-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 12, 2015 |
| Priority date | Dec 25, 2014 |
| Publication date | Jan 16, 2018 |
| Grant date | Jan 16, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A compound of formula (I) or a pharmaceutically acceptable salt, hydrate or prodrug thereof for inhibiting Syk activity,
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treating asthma in a subject having asthma, comprising: administering an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof to the subject 2. The method according to claim 1 , wherein the effective amount of the compound is administered directly to a mast cell of the subject. 3. The method according to claim 1 , wherein the compound is administered in the form of a pharmaceutical composition that contains about 0.0001-50 wt % of the compound. 4. The method according to claim 3 , wherein the composition is administered to the subject at a dosage of 0.001-50 mg/kg body weight/day.
Assignees
Inventors
Classifications
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Antineoplastic agents · CPC title
- A61K31/352Primary
condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)} · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
specific for leukemia · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9868716B2 cover?
- A compound of formula (I) or a pharmaceutically acceptable salt, hydrate or prodrug thereof for inhibiting Syk activity,
- Who is the assignee on this patent?
- Univ Hong Kong Baptist Univ, Univ Shanghai Traditional Chinese Medicine, Shanghai Univ Of Traditional Chinese
- What technology area does this patent fall under?
- Primary CPC classification A61K31/352. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).